\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Events

H.C. Wainwright 23rd Annual Global Investment Conference
 September 13, 2021 -
September 15, 2021
 4:00am - 5:00pm PDT

Mark Erlander, Ph.D., chief executive officer and James Levine, chief financial officer, of Cardiff Oncology, will present and participate in virtual 1x1 investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13 – 15th 2021.

Please access the Company presentation by clicking on the link:

https://journey.ct.events/view/50ff15c3-cb28-455a-bf01-6e3b2c0dcfce